ClinVar Miner

Submissions for variant NM_172107.4(KCNQ2):c.1003C>G (p.Pro335Ala)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Invitae RCV000801187 SCV000940953 pathogenic Early infantile epileptic encephalopathy 2018-11-25 criteria provided, single submitter clinical testing This sequence change replaces proline with alanine at codon 335 of the KCNQ2 protein (p.Pro335Ala). The proline residue is highly conserved and there is a small physicochemical difference between proline and alanine. This variant is not present in population databases (ExAC no frequency). This variant has been observed to be de novo in an individual affected with early infantile epileptic encephalopathy (PMID: Invitae). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). This variant disrupts the p.Pro335 amino acid residue in KCNQ2. Another variant that disrupts this residue has been observed in affected individuals (Invitae, PMID: 28867141), suggesting that it is a clinically significant residue. As a result, variants that disrupt this residue are likely to be causative of disease. For these reasons, this variant has been classified as Pathogenic.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.